Ranbaxy Laboratories Inc.’s drugs manufactured at its plant in India were banned from entering the United States by the Food and Drug Administration (FDA) due to quality concerns, but European regulators say the plant does not pose a risk to public health. The FDA’s ban came after the agency in January announced it had uncovered drug safety violations at the pharmaceutical company’s India plant. FDA investigators found that employees at the plant had re-tested some of the drugs to gain more favorable results after the drugs failed initial tests. They also found that the facility lacked appropriate controls over computerized ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.